News

“It is no use asking for the impossible, such as, say, the exact wiring diagram for a cubic millimeter of brain tissue and the way all its neurons are firing,” Crick wrote in Scientific America ...
The partnership’s main focus is on developing the nasally delivered mRNA vaccine targeting influenza. Credit: mi_viri/Shutterstock. Ethris has partnered with contract development and manufacturing ...
A significant discovery has identified a missing "gatekeeper" protein as the root cause of dry mouth in Sjögren's syndrome — a finding that could change the way the disease is treated.
The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave that legacy—and a $70 billion market—behind.
Supporters say consumers should be protected from unknowingly eating material from novel mRNA vaccines, while critics say the bills would needlessly undermine animal health advances. Bills focused on ...
MRNA, NVAX Price Action: At the time of publication, Moderna shares were down 5.70% at $31.91 and Novavax shares were down 3.37% at $7.30, according to Benzinga Pro.
Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against ...
They found that mRNA-based COVID-19-vaccinations cause a significant and persistent change through acetylation, i.e., the binding of a chemical group to specific, immunologically relevant genes of ...
The vaccine — using messenger RNA (mRNA) technology similar to that found in some Covid vaccines — activated tumour-targeting immune cells that persisted for nearly four years after surgery in ...
Image credit: Shutterstock / Wirestock Creators. The US Food and Drug Administration (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia ...